Sources Sought

Reagents and consumables for Roche immunostainers Sources Sought Notice Solicitation Notice Number: PCA-NCI-04352

Contracting Office Address
Department of Health and Human Services, National Institutes of Health, Office of Acquisitions, OA Office of the Director, OD, 6701 Rockledge Drive, Bethesda, MD, 20892. Introduction
This is a notice issued on behalf of the National Institutes of Health (NIH), Office of Acquisitions, OA Office of the Director, OD, DHHS, UNITED STATES. This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this Sources Sought is to seek the availability and capability of small business concerns, including 8(a) small business and/or small qualified small business concerns [including Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone) Small Businesses, Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-owned Small Businesses (SDVOSB] that are interested in and capable of performing the work described in the statement of work. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.

Background
The National Institutes of Health, National Cancer Institute (NCI), Laboratory of Pathology at the Cancer Center Research (CCR) is seeking small businesses with the ability to provide stains/reagents and consumables and software upgrades needed to conduct immunohistochemical and in situ hybridization testing for cancer diagnostics and research. The reagents and consumables must be compatible with Roche Ultra Plus immunostainers.

STATEMENT OF NEED:

The purpose of the proposed acquisition is to issue a new Indefinite Delivery Indefinite Quantity (IDIQ) contract to ensure that the Laboratory of Pathology at the Cancer Center Research (CCR) can continue to purchase stains/reagents and consumables and software upgrades needed to conduct immunohistochemical and in situ hybridization testing for cancer diagnostics and research. These stains/reagents have become an essential part of cancer diagnosis and have an equally important role in the diagnosis of many infectious diseases. The period of performance for this requirement shall be a base period plus four option periods.

The reagents and consumables must be compatible with Roche Ultra Plus immunostainers. The Contractor shall provide all resources necessary to accomplish the tasks and deliverables described in this Statement of Work (SOW).